Eunhee Lee

1PUBLICATIONS
0CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 17, 2023
Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release.

Eunhee Lee, Shinai Lee, Sumyeong Park

Pageof 1

Frequent Collaborators